UC HEALTH LINE: For Parkinson's Prevention, Is Espresso Worth a Shot?
CINCINNATICoffee has been the center of a hot health debate over the years, with studies suggesting it can lower risk for diabetes and colon cancer, lift your mood, treat headaches, decrease risk for developing cavities and even reduce liver damage in heavy drinkers.
And now, says UC neurologist Alberto Espay, MD, coffeeparticularly its natural stimulant known as caffeineis turning heads as a possible prevention for Parkinsons disease.
Recent studies have shown that coffee drinkers are less likely to develop Parkinsons. And new laboratory studies have looked at how caffeine works in the brain and determined that it can enhance the effects of the most common drug given to Parkinsons patients, levodopa.
In fact, scientists are currently working on drugs for Parkinsons that act on the brain in the same way caffeine does, says Espay.
With all we know about coffee, Espay says, if you drink it, keep drinking. And if you dont, it wouldnt hurt to start.
Its unclear what amount of coffee must be consumed to have the most benefit, he adds. But because coffee has no clear health risks, go for it. Just be sure to talk with your doctor first if you have high blood pressure or other health concerns.
Parkinsons is a disease that results from the loss of a group of brain cells that produce the natural neurotransmitter dopamine. Without dopamine, brain nerve cells dont fire properly, causing an inability to control movement.
The most visible signs of the diseasetremors, difficulty with gait and balance, rigidity and stiffness or general slowness when movingare blamed on this lack of dopamine production in the brain.
But, Espay says, there are other signs and symptoms of Parkinsons disease that usually appear much earlier and are not directly related to insufficient dopamine. They include sleep difficulties, loss of sense of smell, constipation and depression.
The Parkinsons Disease Foundation estimates as many as 1 million Americans have Parkinsons disease and many go undiagnosed.
Tags
Related Stories
Can new rules in Ohio address a pharmacy staffing shortage and...
May 17, 2024
The University of Cincinnati's Michael Hegener joined WVXU's Cincinnati Edition to discuss recent rules released by the Ohio Board of Pharmacy designed to address pharmacy staffing.
Is ketamine the answer to treatment-resistant depression?
May 16, 2024
The University of Cincinnati's Stephen Rush joined WVXU's Cincinnati Edition to discuss the use of ketamine and esketamine to treat treatment-resistant depression.
UC study: Severe ischemic strokes rare in total patient...
May 15, 2024
The University of Cincinnati’s Yasmin Aziz will present research at the European Stroke Organisation Conference that found severe ischemic strokes with the most severe damage are rare in the total stroke patient population.